{{htmlmetatags> metatag-keywords=(COVID19, Vaccins) metatag-og:title=(Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Chen Y, et al, Expert Rev Vaccines 2023.) metatag-description=(Traduction du résumé de l'article : Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Chen Y, et al, Expert review of vaccines 2023.) metatag-og:type=article metatag-article:published_time=2024-03-27 metatag-article:modified_time=2024-03-27 }} {{page>:priv:keywords&nofooter&noeditbtn}} ~~NOTOC~~ {{pmid>addtt:37877219|Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older.}} {{pmid>addhash_fr:37877219|COVID19, Vaccins}} ====== Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Chen Y, et al, Expert Rev Vaccines 2023. ====== {{tag>COVID19 }} {{tag>Vaccins}} * **Proposé le :** 27/03/2024 07:07:13 * **Par :** [[:user:Bot]] * **Avec la version du site :** * **Revu par :** * //Mettre votre nom d'utilisateur// * //Mettre votre nom d'utilisateur// {{tag>Proposé_à_relecture 2024-03 Non_attribué Non_finalisé}} {{page>:veille:info:part_authors_instructions&noindent&nolink&nofooter&noeditbtn}} ===== Résumé et points clés ===== {{pmid>abstract_html:37877219}} ===== Références de l'article ===== {{pmid>listgroup:37877219}} ---- {{page>:veille:pm:discussion:37877219&nofooter&nolink&noindent}} [[:veille:pm:discussion:37877219?do=edit|Éditer la discussion]] ---- ===== Références ===== ~~REFNOTES~~ {{page>:start_news:start_newsletter&noident&nofooter&noeditbtn}}